Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cell Therapeutics, Inc. --cti-- Management Conference Call.


Health Medical and Business Editors

SEATTLE--(BW HealthWire)--May 16, 2000

Cell Therapeutics, Inc. (cti)(Nasdaq:CTIC CTIC Conservation Technology Information Center
CTIC Chicago Title Insurance Company
CTIC Centro Tecnológico de la Información y de la Comunicación (Spanish: Center for the Development of Information and Communication Technologies in Asturias) 
)

On Tuesday, May 16, 2000 at 9:00 a.m. Eastern/6:00 a.m. Pacific, members of cti's management team will host a conference call to discuss:

-- Priority Review Notification from the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 on Arsenic TriOxide arsenic trioxide Warning - Hazardous drug!

Trisenox

Pharmacologic class: Nonmetallic element, white arsenic

Therapeutic class: Antineoplastic

 

(ATO ATO Australian Taxation Office
ATO Ambito Territoriale Ottimale (Italy)
ATO Alpha Tau Omega
ATO Air Traffic Organization (FAA)
ATO Arab Towns Organization
ATO Air Tasking Order
ATO Assemble To Order
)

-- Q1 2000 financials

Tuesday, May 16

9:00 A.M. Eastern/6:00 A.M. Pacific

888/493-1552 (US Participants)

212/271-4756 (International)

www.cticseattle.com
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 15, 2000
Words:81
Previous Article:Matthews Studio Group Reports Second Quarter Results.
Next Article:Newstream.com digest of available free multimedia story packages for journalists.
Topics:



Related Articles
Cell Therapeutics announces first quarter results.
Cell Therapeutics Announces Second Quarter Results.
Cell Therapeutics, Inc. Announces Third Quarter Results.
Former Chiron Executive Appointed Chief Operating Officer at Cell Therapeutics Inc.
Cell Therapeutics, Inc. Reports 1998 Financial Results.
Cell Therapeutics Inc. cti Announces Quarterly Management Conference Call.
MD Anderson Cancer Center Data Suggests 400% Improvement in Anti-Cancer Activity Over Current Marketed Form of Taxol.
Cell Therapeutics, Inc. Initiates Second Efficacy Trial of Apra: a New Treatment for Cancer.
Cell Therapeutics, Inc. to Submit NDA by End of March.
Cell Therapeutics, Inc. Submits New Drug Application for Arsenic Trioxide.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles